HomeCompareBOIRF vs O

BOIRF vs O: Dividend Comparison 2026

BOIRF yields 4.58% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 O wins by $9.5K in total portfolio value· pulled ahead in Year 6
10 years
BOIRF
BOIRF
● Live price
4.58%
Share price
$30.00
Annual div
$1.37
5Y div CAGR
-6.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.7K
Annual income
$277.87
Full BOIRF calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.18
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,098.20
Full O calculator →

Portfolio growth — BOIRF vs O

📍 O pulled ahead of the other in Year 6

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBOIRFO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BOIRF + O cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BOIRF pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BOIRF
Annual income on $10K today (after 15% tax)
$389.02/yr
After 10yr DRIP, annual income (after tax)
$236.19/yr
O
Annual income on $10K today (after 15% tax)
$448.90/yr
After 10yr DRIP, annual income (after tax)
$4,333.47/yr
At 15% tax rate, O beats the other by $4,097.28/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BOIRF + O for your $10,000?

BOIRF: 50%O: 50%
100% O50/50100% BOIRF
Portfolio after 10yr
$29.5K
Annual income
$2,688.04/yr
Blended yield
9.13%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

BOIRF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
4.4
Piotroski
6/9
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.6% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BOIRF buys
0
O buys
0
No recent congressional trades found for BOIRF or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBOIRFO
Forward yield4.58%5.28%
Annual dividend / share$1.37$3.23
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-6.9%15.1%
Portfolio after 10y$24.7K$34.2K
Annual income after 10y$277.87$5,098.20
Total dividends collected$3.5K$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusBuyHold

Year-by-year: BOIRF vs O ($10,000, DRIP)

YearBOIRF PortfolioBOIRF Income/yrO PortfolioO Income/yrGap
1$11,126$426.09$10,818$607.86+$308.00BOIRF
2$12,317$412.48$11,786$741.30+$531.00BOIRF
3$13,577$397.33$12,944$910.50+$633.00BOIRF
4$14,908$381.06$14,343$1,127.28+$565.00BOIRF
5$16,316$364.08$16,053$1,408.17+$263.00BOIRF
6← crossover$17,805$346.69$18,167$1,776.65$362.00O
7$19,380$329.18$20,815$2,266.60$1.4KO
8$21,049$311.76$24,179$2,927.66$3.1KO
9$22,817$294.61$28,521$3,833.95$5.7KO
10$24,692$277.87$34,218$5,098.20$9.5KO

BOIRF vs O: Complete Analysis 2026

BOIRFStock

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. In addition, it provides dietary supplement; Dermoplasmine stick, baume, and mousse to treat dry lips and skin; Mag' Nuit, a formula to fall asleep; Arnitrosium for joint pain; Castor Equi Boiron ointment for treatment of cracked skin; and Storinyl, a syrup to treat colds. Further, it offers herbal medicines, such as Canephron to increase the amount of urine and to improve urinary elimination; moisturizing baby milk; and medical devices, including a range of COVID self-tests and rapid antigenic tests. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.

Full BOIRF Calculator →

OREIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this BOIRF vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BOIRF vs SCHDBOIRF vs JEPIBOIRF vs KOBOIRF vs MAINBOIRF vs STAGBOIRF vs ADCBOIRF vs NNNBOIRF vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.